Welcome to our dedicated page for RTX news (Ticker: RTX), a resource for investors and traders seeking the latest updates and insights on RTX stock.
RTX Corp (NYSE: RTX) delivers cutting-edge solutions across aerospace and defense through its Collins Aerospace, Pratt & Whitney, and Raytheon segments. This news hub provides investors and industry professionals with centralized access to official updates and market analysis.
Track critical developments including quarterly earnings, defense contract awards, and aviation technology innovations. Our curated collection ensures you stay informed about strategic partnerships, regulatory milestones, and operational advancements shaping this industrial leader.
Discover press releases covering next-generation engine developments, aerospace component innovations, and defense system upgrades. Bookmark this resource for real-time updates on RTX's position in global aviation infrastructure and national security solutions.
RTX's Raytheon has secured a $333 million contract from the U.S. Navy for the production of Standard Missile-6 (SM-6) Block IA missiles. The SM-6 is a versatile weapon system that provides both offensive and defensive capabilities, supporting anti-air, anti-surface warfare, and sea-based terminal ballistic missile defense in a single solution.
The missile has demonstrated its effectiveness through successful deployments on various U.S. Navy ships, unmanned vessels, and land-based launchers. Notably, in March 2024, it successfully intercepted a medium-range ballistic missile target during the Flight Test Aegis Weapon System exercise.
Production will take place across Raytheon facilities in Tucson, Huntsville, Andover, and Dine, with project completion expected by 2027.
RTX (NYSE: RTX) has announced it will release its fourth quarter and full year 2024 earnings results on Tuesday, January 28, 2025, before market opening. The company will host a conference call at 8:30 a.m. ET to discuss the results and provide its 2025 outlook. The conference call will be available via webcast on RTX's website and will include a downloadable presentation. A replay of the call will be made available after the event.
RTX's Raytheon has secured a $946 million contract to provide additional Patriot air and missile defense systems to Romania, marking the country's third Patriot order. The contract encompasses fire units including radars, control stations, and missiles.
Raytheon maintains partnerships with Romanian defense companies as part of its Patriot global supply chain network. The Patriot system, currently employed by 19 countries, is the world's only combat-proven ground-based air and missile defense capability that can counter advanced long-range cruise missiles, tactical ballistic missiles, and various air-breathing threats. The system has demonstrated its effectiveness against sophisticated aerial threats and complex raid attacks.
RTX's Raytheon and Ursa Major have successfully completed a missile flight test of an advanced long-range solid rocket motor for the U.S. Army. The collaboration leverages digital engineering to accelerate development of affordable precision munitions. Ursa Major has conducted nearly 300 static test fires this year using additive manufacturing techniques, demonstrating rapid development capabilities.
The partnership aims to provide the U.S. Army with smart munitions that are more cost-effective than current systems. The program will continue with manufacturing improvements and additional flight tests in 2025, targeting qualification in 2026. RTX Ventures' 2023 investment in Ursa Major supports this initiative to address national security requirements through innovative rocket motor technologies.
Collins Aerospace, an RTX business, has unveiled a comprehensive avionics modernization program for Beechcraft King Air and Hawker aircraft. The initiative includes upgrades for Pro Line Fusion® and Pro Line 21™ advanced avionics systems, focusing on enhancing aircraft performance, safety, and pilot efficiency.
The program encompasses upgrades for King Air 200 and 300 series aircraft, transitioning from Pro Line 21 to Pro Line Fusion, along with modernization options for Hawker 750, 800, and 900 series aircraft. The Pro Line Fusion system features touchscreen displays and advanced navigation tools, while Pro Line 21 provides integrated digital cockpit capabilities.
Pratt & Whitney, an RTX business, has received FAA certification for its GTF engine to power the Airbus A321XLR aircraft, with entry into service expected in 2025. The PW1100G-JM engine certification marks a significant milestone for the GTF program. 13 customers have selected GTF engines for 217 A321XLR aircraft, with over 2,100 GTF-powered aircraft delivered globally to more than 80 customers.
The GTF engines provide up to 20% better fuel efficiency compared to previous generation engines, saving operators 2 billion gallons of fuel and 20 million metric tons of CO2 since 2016. The upcoming GTF Advantage engine will offer 4-8% higher takeoff thrust with up to 1% additional fuel efficiency and longer time on wing.
Raytheon, an RTX business, announced successful testing of its Lower Tier Air and Missile Defense Sensor (LTAMDS) by U.S. Army soldiers. The system effectively guided Patriot Advanced Capability-3 interceptors to defeat cruise and ballistic missile surrogates. The 360-degree radar, integrated with the Integrated Battle Command System, demonstrated successful detection, tracking, and engagement capabilities.
The program is progressing towards Milestone C in Q2 FY2025, transitioning from development to production. In August 2024, Raytheon secured a $2 billion contract to deliver eight radars for the U.S. and Poland, marking Poland as the first international customer. More than a dozen countries are showing interest in LTAMDS, with six radars currently undergoing simultaneous testing across multiple locations.
RTX's Raytheon UK has successfully completed the first live-firing test of its High-Energy Laser Weapon System (HELWS) with the British Army, targeting moving aerial targets at a military range in Wales. This marks the first instance of British soldiers operating a high-energy laser weapon mounted on an armoured vehicle as part of the Ministry of Defence's Land Laser Directed Energy Weapon demonstrator programme.
The system, which uses advanced sensors and tracking systems to direct an intense energy beam at targets, has demonstrated effectiveness in real-world conditions. The test was conducted through collaboration between Raytheon UK and Team Hersa, representing a significant advancement in defense technology integration.
Collins Aerospace, an RTX business, demonstrated a groundbreaking cross-domain networking capability during exercise Keen Sword with the III Marine Expeditionary Force in Okinawa, Japan. The technology successfully integrated unclassified data from non-traditional sensors into a classified fires network, enhancing situational awareness for forces in early conflict stages.
The system automated data routing across different security classification levels and utilized satellite networks to establish a secure transport layer. Notable features include rapid setup time of less than an hour and the ability to seamlessly connect commercial nodes with government systems. This advancement supports Marine Corps Command and Control objectives by enabling expeditionary machine-to-machine data transfers for faster decision-making processes.
RTX BBN Technologies has been awarded a contract to support ARPA-H's Chatbot Accuracy and Reliability Evaluation (CARE) initiative. The company will develop the Monitoring, Evaluation and Diagnosing of Intelligent Chatbots (MEDIC) system to assess medical chatbots' reliability in healthcare settings.
The project aims to address critical limitations in current AI healthcare systems, which often generate inaccurate or misleading responses. The MEDIC framework will include integration of healthcare stakeholder insights, medical text validation, demographic-specific prompt engineering, and advanced information extraction techniques to detect inaccuracies.
The initiative involves collaboration with Johns Hopkins University, Johns Hopkins University School of Medicine, and Howard University Hospital, with work being conducted in Cambridge, Baltimore, and Washington, D.C.